<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id>
<journal-title>Frontiers in Aging Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Aging Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1663-4365</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnagi.2021.745381</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Cortical Thickness Differences Are Associated With Chemical Synaptic Transmission Upregulated Genes in Degeneration of Mild Cognitive Impairment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cai</surname> <given-names>Suping</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/266012/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Kexin</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/945986/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname> <given-names>Fan</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Xuwen</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname> <given-names>Sijia</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1185927/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Yubo</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Huang</surname> <given-names>Liyu</given-names></name>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/234732/overview"/>
</contrib>
</contrib-group>
<aff><institution>School of Life Sciences and Technology, Xidian University</institution>, <addr-line>Xi&#x2019;an</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Changiz Geula, Northwestern University, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Joon-Kyung Seong, Korea University, South Korea; Agenor Limon, The University of Texas Medical Branch at Galveston, United States</p></fn>
<corresp id="c001">&#x002A;Correspondence: Suping Cai, <email>caisp@xidian.edu.cn</email>; <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0001-8605-0874">orcid.org/0000-0001-8605-0874</ext-link></corresp>
<corresp id="c002">Liyu Huang, <email>huangly@mail.xidian.edu.cn</email>; <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0001-6534-2712">orcid.org/0000-0001-6534-2712</ext-link></corresp>
<fn fn-type="equal" id="fn002"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>13</volume>
<elocation-id>745381</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>07</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>10</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2021 Cai, Huang, Yang, Wang, Wu, Wang and Huang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Cai, Huang, Yang, Wang, Wu, Wang and Huang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Mild cognitive impairment (MCI) is a transition between normal cognition (NC) and Alzheimer&#x2019;s disease (AD). Differences in cortical thickness (&#x0394;CT) have been reported in cases that degenerate from MCI to AD. The aspects of genetic and transcriptional variation related to &#x0394;CT are vague. In this study, using an 8-year longitudinal follow-up outcome, we investigated the genetic correlates of &#x0394;CT in MCI subjects with degeneration from MCI to AD (MCI_AD). We employed partial least squares regression (PLSR) on brain T1-weighted magnetic resonance imaging (MRI) images of 180 participants [143 stable MCI (MCI_S) participants and 37 MCI_AD participants] and brain gene expression data from the Allen Institute for Brain Science (AIBS) database to investigate genes associated with &#x0394;CT. We found that upregulated PLS component 1 &#x0394;CT-related genes were enriched in chemical synaptic transmission. To verify the robustness and specificity of the results, we conducted PLSR analysis invalidation and specificity datasets and performed weighted gene co-expression network analysis instead of PLSR for the above three datasets. We also used gene expression data in the brain prefrontal cortex from the Gene Expression Omnibus (GEO) database to indirectly validate the robustness and specificity of our results. We conclude that transcriptionally upregulated genes involved in chemical synaptic transmission are strongly related to global &#x0394;CT in MCI patients who experience degeneration from MCI to AD.</p>
</abstract>
<kwd-group>
<kwd>cortical thickness differences</kwd>
<kwd>chemical synaptic transmission</kwd>
<kwd>partial least squares regression</kwd>
<kwd>weighted gene co-expression network analysis</kwd>
<kwd>structural magnetic resonance images</kwd>
<kwd>cortical gene expression</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="64"/>
<page-count count="12"/>
<word-count count="8448"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="S1">
<title>Introduction</title>
<p>Mild cognitive impairment (MCI) refers to the prodrome of Alzheimer&#x2019;s disease (AD) (<xref ref-type="bibr" rid="B55">Stephan et al., 2012</xref>). Longitudinal studies have found that some MCI patients maintain an MCI state, and some MCI patients experience degeneration to AD over a follow-up period (<xref ref-type="bibr" rid="B39">Morris and Price, 2001</xref>). The potential reason for this difference in MCI conversion is worth exploring. Structural abnormalities in brain morphology, such as a decrease or increase in cortical thickness in particular brain regions, are an important biomarker of MCI or AD (<xref ref-type="bibr" rid="B32">Lerch et al., 2005</xref>; <xref ref-type="bibr" rid="B43">Querbes et al., 2009</xref>; <xref ref-type="bibr" rid="B13">Filippi et al., 2020</xref>). Previous studies have reported that aberrant cortical thickness is a potential biomarker for tracking cognitive and neuropathological symptoms of MCI progression (<xref ref-type="bibr" rid="B25">Julkunen et al., 2009</xref>, <xref ref-type="bibr" rid="B24">2010</xref>; <xref ref-type="bibr" rid="B33">Li et al., 2011</xref>). However, it is not clear which aspects of variation are related to the differences in cortical morphology in MCI patients.</p>
<p>Complex genetic risk factors are believed to contribute to 70% of AD risk (<xref ref-type="bibr" rid="B29">Lambert et al., 2013</xref>). Varying degrees of genetic variation have a significant relationship with the progression of MCI (<xref ref-type="bibr" rid="B28">Lacour et al., 2017</xref>). A meta-analysis using blood from MCI and AD patients found that abnormal transcription was related to MCI progression and might be applied to diagnostic and prognostic biomarkers (<xref ref-type="bibr" rid="B4">Bottero and Potashkin, 2019</xref>). Several other genetic studies have revealed that the underlying pathophysiology of AD is sophisticated, encompassing up to thirty associated risk genes that are involved in a set of biological processes, such as lipid metabolism and immune system function (<xref ref-type="bibr" rid="B53">Sims et al., 2017</xref>; <xref ref-type="bibr" rid="B56">Tasaki et al., 2018</xref>; <xref ref-type="bibr" rid="B22">Jansen et al., 2019</xref>; <xref ref-type="bibr" rid="B27">Kunkle et al., 2019</xref>). <xref ref-type="bibr" rid="B2">Berchtold et al. (2013)</xref> revealed that many synaptic genes were upregulated in MCI patients (such as neurotransmitter receptors and synaptic stabilization genes). Their results suggest that a mechanism that rebalances synaptic transmission exists in the brains of MCI patients. In other words, these upregulated genes may be responsible for AD risk or may compensate for upstream biological and cellular changes. The sophistication of AD pathology indicates that patients may need treatment that is tailored with regard to affected biological processes.</p>
<p>Despite crucial progress in comprehending brain cortical morphology and genetic risk for MCI or AD, a question remains: is there an association between differences in cortical morphology and transcriptional gene expression? Recently, our research team applied weighted gene co-expression network analysis (WGCNA) (<xref ref-type="bibr" rid="B62">Zhang and Horvath, 2005</xref>; <xref ref-type="bibr" rid="B30">Langfelder and Horvath, 2008</xref>) and preliminarily bridged the brain T1-magnetic resonance imaging (MRI) features and transcriptional expression in MCI participants who progressed to AD (<xref ref-type="bibr" rid="B59">Wang et al., 2021</xref>). <xref ref-type="bibr" rid="B47">Romero-Garcia et al. (2019)</xref> applied partial least squares regression (PLSR) to determine that synaptic and transcriptionally downregulated genes are associated with cortical thickness differences in autism. PLSR is a data reduction technique closely related to principal component analysis (PCA) and ordinary least squares (OLS) regression (<xref ref-type="bibr" rid="B58">Tobias, 1995</xref>). One of the PLSR components is calculated to explain the maximum covariance between the dependent and independent variables. Coincidently, the maximum covariance between differences in cortical morphology and transcriptional gene expression might be calculated by PLSR. Several previous studies have used PLSR to explore the relationship between brain features and gene expression in major depressive disorder or healthy adolescence (<xref ref-type="bibr" rid="B46">Romero-Garcia et al., 2020</xref>; <xref ref-type="bibr" rid="B34">Li et al., 2021</xref>).</p>
<p>Intuitively, it is possible that risk gene mutations lead to changes in brain structural characteristics, which in turn contribute to changes in clinical phenotypes. At a deeper level, considering the heterogeneity in the results of MCI or AD imaging studies (<xref ref-type="bibr" rid="B52">Shirotani et al., 2017</xref>), it is crucial to investigate how the genetic risk is related to the cortical morphological variation observed in MCI patients. Therefore, the purpose of this research was to detect the molecular correlation of disease-related neuroanatomical differences. Here, 180 participants with MCI were followed up for 8 years. Thirty-seven patients with MCI progressed to AD during the 8 years; the rest of the 143 MCI subjects remained in the MCI state. Focusing on cortical thickness differences (&#x0394;CT) from the 180 MCI participants, we asked two key questions: (1) which genes and biological processes are related to &#x0394;CT in degeneration from MCI to AD? and (2) what is the spatial profiling of the genetic expression related to &#x0394;CT? We conducted PLSR and WGCNA analyses and combined the &#x0394;CT measured by T1-MRI in MCI patients with postmortem gene expression data downloaded from the Allen Institute for Brain Science (AIBS) (<xref ref-type="bibr" rid="B19">Hawrylycz et al., 2012</xref>, <xref ref-type="bibr" rid="B18">2015</xref>) to address the two questions. We then validated the robustness and specificity of our results with validation datasets. The flow chart of the current research ideas is shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Flowchart of this study. <bold>(A)</bold> Cortical thickness difference (&#x0394;CT) of 308 brain regions between the MCI_S and MCI_AD groups. <bold>(B)</bold> Regional expression of 20,647 genes in 308 brain regions from the AIBS. <bold>(C)</bold> Partial least squares regression (PLSR) analysis using gene expression as a predictor variable and &#x0394;CT as a response variable. <bold>(D)</bold> PLSR weights of all genes in line with its contribution to the overall model in each component (FDR correction, z-score &#x003E; 1.96). <bold>(E)</bold> Upregulated genes are tested for enrichment analysis and spatial expression of von Economo classes. <bold>(F)</bold> Validation of robustness and specificity of our results. <bold>(G)</bold> Validation of robustness and specificity.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-13-745381-g001.tif"/>
</fig>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>Ethics Statement</title>
<p>The T1-MRI images we evaluated for this work were from the Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) database.<sup><xref ref-type="fn" rid="footnote1">1</xref></sup> We confirm that all procedures performed in this study involving human participants were in accordance with the ethical standards of the ADNI consortium Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants or surrogates (see text footnote 1).</p>
</sec>
<sec id="S2.SS2">
<title>Discovery Dataset: T1-Magnetic Resonance Imaging Data and Quality Control</title>
<p>We tracked 189 MCI subjects from the ADNI database for 8 years. On the last record (September 2020), 147 MCI subjects were stable in the MCI state (MCI_S), and 42 MCI subjects had progressed to AD (MCI_AD). The timeline of the transition to AD is shown in <xref ref-type="supplementary-material" rid="TS1">Supplementary Table 1</xref>. T1-weighted magnetization prepared rapid gradient echo (MPRAGE) MRI data at baseline (tracking start time: September 2012) were used. The thickness of the cortex was obtained employing FreeSurfer (<xref ref-type="bibr" rid="B14">Fischl, 2012</xref>). The brain gray matter was parcellated into 308 cortical regions, and the mean cortical thickness for the 308 regions was obtained. The detailed quality control and neuroimaging processing are shown in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>. The final sample consisted of 143 MCI_S and 37 MCI_AD patients matched by sex and age. Details are in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Demographic information in discovery dataset, validation dataset 1 and specificity dataset 1.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Dataset</td>
<td valign="top" align="center" colspan="2">Discovery dataset (ADNI)</td>
<td valign="top" align="center" colspan="2">Validation dataset 1 (ADNI)</td>
<td valign="top" align="center" colspan="2">Specificity dataset 1 (ADNI)</td>
</tr>
<tr>
<td valign="top" align="center"></td>
<td valign="top" align="center" colspan="2"><hr/></td>
<td valign="top" align="center" colspan="2"><hr/></td>
<td valign="top" align="center" colspan="2"><hr/></td>
</tr>
<tr>
<td valign="top" align="left">Groups</td>
<td valign="top" align="center">MCI_S<sup><xref ref-type="table-fn" rid="t1fn3">a</xref></sup></td>
<td valign="top" align="center">MCI_AD</td>
<td valign="top" align="center">NC_S<sup><xref ref-type="table-fn" rid="t1fn4">b</xref></sup></td>
<td valign="top" align="center">MCI_S<sup><xref ref-type="table-fn" rid="t1fn3">a</xref></sup></td>
<td valign="top" align="center">NC_S<sup><xref ref-type="table-fn" rid="t1fn4">b</xref></sup></td>
<td valign="top" align="center">NC_MCI</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><italic>n</italic></td>
<td valign="top" align="center">143</td>
<td valign="top" align="center">37</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">143</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">30</td>
</tr>
<tr>
<td valign="top" align="left">Sex (M/F)</td>
<td valign="top" align="center">(80/63)</td>
<td valign="top" align="center">(26/11)</td>
<td valign="top" align="center">(21/32)</td>
<td valign="top" align="center">(80/63)</td>
<td valign="top" align="center">(21/32)</td>
<td valign="top" align="center">(16/14)</td>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td valign="top" align="center">71.41 &#x00B1; 7.59</td>
<td valign="top" align="center">73.35 &#x00B1; 7.19</td>
<td valign="top" align="center">75.45 &#x00B1; 5.96</td>
<td valign="top" align="center">71.41 &#x00B1; 7.59</td>
<td valign="top" align="center">75.45 &#x00B1; 5.96</td>
<td valign="top" align="center">77.57 &#x00B1; 6.24</td>
</tr>
<tr>
<td valign="top" align="left">CDR</td>
<td valign="top" align="center">&#x2004;&#x2004;0.05 &#x00B1; 0.00</td>
<td valign="top" align="center">&#x2004;&#x2004;0.05 &#x00B1; 0.00</td>
<td valign="top" align="center">&#x2004;&#x2004;0.00 &#x00B1; 0.00</td>
<td valign="top" align="center">&#x2004;&#x2004;0.05 &#x00B1; 0.00</td>
<td valign="top" align="center">&#x2004;&#x2004;0.00 &#x00B1; 0.00</td>
<td valign="top" align="center">&#x2004;&#x2004;0.05 &#x00B1; 0.00</td>
</tr>
<tr>
<td valign="top" align="left">MMSE</td>
<td valign="top" align="center">28.31 &#x00B1; 1.57</td>
<td valign="top" align="center">27.57 &#x00B1; 1.82</td>
<td valign="top" align="center">29.09 &#x00B1; 1.06</td>
<td valign="top" align="center">28.31 &#x00B1; 1.57</td>
<td valign="top" align="center">29.09 &#x00B1; 1.06</td>
<td valign="top" align="center">&#x2004;&#x2004;28.63 &#x00B1; 1.847</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t1fn1"><p><italic>Data are the mean &#x00B1; standard deviation; statistical tests showed no significant differences in sex, age, MMSE or CDR (<italic>p</italic> &#x003E; 0.01, FDR correction). The n-row represents the number of participants.</italic></p></fn>
<fn id="t1fn2"><p><italic>MCI_S: stable MCI; MCI_AD: transition from MCI to AD; NC_S: remaining normal cognitive state; NC_MCI: conversion from NC to MCI; CDR: clinical dementia rate; MMSE: Mini-Mental State Examination.</italic></p></fn>
<fn id="t1fn3"><p><italic><sup><italic>a</italic></sup>Indicates that the same MCI_S group was used for both the discovery and validation datasets.</italic></p></fn>
<fn id="t1fn4"><p><italic><sup><italic>b</italic></sup>Indicates that the same NC_S group was used for both the validation and specificity datasets.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
<p>Differences in cortical thickness (&#x0394;CT) were calculated as follows. The cortical thickness (CT) of MCI_S has a matrix of 308 &#x00D7; 143, and MCI_AD has a matrix of 308 &#x00D7; 37. For instance, brain region <italic>A</italic> in the MCI-S group has a mean CT<sub>MCI&#x2013;S</sub> ((CT<sub>1</sub> + CT<sub>2</sub>&#x2026;CT<sub>143</sub>)/143), and in the MCI_AD group, it has a mean CT<sub>MCI_AD</sub> ((CT<sub>1</sub> + CT<sub>2</sub>&#x2026;CT<sub>37</sub>)/37). Then, the &#x0394;CT of brain region <italic>A</italic> is the mean CT<sub>MCI&#x2013;S</sub> minus the mean CT<sub>MCI_AD</sub>. As there are 308 cortical regions, the &#x0394;CT has a matrix of 308 &#x00D7; 1.</p>
</sec>
<sec id="S2.SS3">
<title>Discovery Dataset: Gene Expression Data</title>
<p>The genetic expression dataset was acquired from the AIBS database<sup><xref ref-type="fn" rid="footnote2">2</xref></sup> (<xref ref-type="bibr" rid="B19">Hawrylycz et al., 2012</xref>, <xref ref-type="bibr" rid="B18">2015</xref>). We evaluated T1-MRI images from each AIBS donor to determine the brain structure corresponding to each tissue sample. We used FreeSurfer (fsaverage) to parcellate the brain structure into 308 cortical regions (<xref ref-type="bibr" rid="B14">Fischl, 2012</xref>); the brain structure was then warped from the anatomical space into the surface reconstruction of each donor&#x2019;s brain from the AIBS. Pertinently, 20,647 gene expression values were provided by the AIBS. Thus, a 308 &#x00D7; 20,647 matrix that included the whole genome expression values for the 308 brain regions was obtained after processing (<xref ref-type="bibr" rid="B48">Romero-Garcia et al., 2018</xref>). More details are shown in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>. The codes used to process these data are in this link.<sup><xref ref-type="fn" rid="footnote3">3</xref></sup> Brain imaging was performed using a BrainNet viewer (<xref ref-type="bibr" rid="B60">Xia et al., 2013</xref>).</p>
</sec>
<sec id="S2.SS4">
<title>Discovery Dataset: Partial Least Squares Regression Analysis</title>
<p>Partial least squares regression was employed to ascertain which genes had a significant association with &#x0394;CT. Then, weighted partial least squares (PLS) values that were z-transformed for each gene were obtained [false discovery rate (FDR) correction, adjusted <italic>p</italic> &#x003C; 0.05]. We chose genes that passed FDR correction with both positive and negative weights for the next step. The detailed steps of the PLSR analysis and the bases of choosing the PLS components are described in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>.</p>
</sec>
<sec id="S2.SS5">
<title>Discovery Dataset: Enrichment Analysis</title>
<p>We used the Metascape tool<sup><xref ref-type="fn" rid="footnote4">4</xref></sup> (<xref ref-type="bibr" rid="B63">Zhou et al., 2019</xref>) to perform enrichment analysis with the Benjamini&#x2013;Hochberg FDR correction (<italic>q</italic> &#x003C; 0.05) of the significant genes from selected PLSR components [Gene Ontology (GO) biological processes, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and protein--protein interaction networks]. We performed tissue-specific enrichment analysis using Enrichr<sup><xref ref-type="fn" rid="footnote5">5</xref></sup> [FDR correction (<italic>q</italic> &#x003C; 0.05)] (<xref ref-type="bibr" rid="B6">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="B26">Kuleshov et al., 2016</xref>). Detailed information is shown in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>.</p>
</sec>
<sec id="S2.SS6">
<title>Validation and Specificity</title>
<p>To verify the robustness of our results, we utilized the other independent dataset, which was from the ADNI database, as the validation dataset. Two groups, one consisting of 143 MCI_S patients and the other consisting of 53 individuals with normal cognition (NC), served as validation dataset 1. PLSR analysis and enrichment analysis were conducted in validation dataset 1. To verify that our results were MCI specific, we used another independent dataset as the specificity dataset, which was also from the ADNI database. Eighty-three normal cognitive participants were longitudinally followed for 8 years. During the 8-year period, 30 participants transitioned from normal cognitive function to MCI (NC_MCI). The other 53 participants remained in a normal cognitive state (NC_S). We selected the baseline T1-MRI images of 83 normal cognitive participants (53 individuals with NC and 30 NC_MCI participants) as specificity dataset 1. Gene expression data were the same as the discovery dataset. To process T1-weighted MRI images, PLSR analysis and enrichment analysis of the two datasets were conducted with the same pipeline as described above.</p>
</sec>
<sec id="S2.SS7">
<title>Validation Using the Weighted Gene Co-expression Network Analysis Method</title>
<p>To remove the influence of the method on the results, we performed WGCNA instead of PLSR to verify the reliability of our initial results in the discovery and validation datasets. Detailed processes are provided in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>.</p>
</sec>
<sec id="S2.SS8">
<title>Indirect Validation and Specificity Analyses</title>
<p>Tissue-specific enrichment analysis results showed that the prefrontal lobe was the coincident brain tissue in both the validation and discovery datasets. Therefore, we performed validation and specificity analyses purely from the perspective of gene expression data from the prefrontal cortex to indirectly verify our results. Validation dataset 2 comprises microarray data of 56 AD patients and 44 normal controls from the Gene Expression Omnibus (GEO) database. Specificity dataset 2 of 36 vascular dementia (VaD) patients and 44 normal controls was also acquired from the GEO database. Detailed information is shown in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>.</p>
</sec>
<sec id="S2.SS9">
<title>Von Economo Classification for Partial Least Squares Component 1</title>
<p>For the selected PLSR component, we also conducted spatial expression profiling of PLSR component 1 across five Von Economo (VE) classifications (<xref ref-type="bibr" rid="B11">Economo et al., 2008</xref>) and two additional subtype classifications, including the limbic system and old cortex and insular lobe (<xref ref-type="bibr" rid="B64">Zilles and Amunts, 2012</xref>).</p>
</sec>
<sec id="S2.SS10">
<title>Assigning &#x0394;CT Related Genes to Cell Types and Enrichment Analysis in the Discovery Dataset</title>
<p>We used the secondary data of cellular markers (gene sets corresponding to each cell type) for reference. The secondary data of cellular markers are based on the data from the AIBS database. Gene sets corresponding to each cell type is available data from <xref ref-type="bibr" rid="B34">Li et al. (2021)</xref>. Cell-specific gene set is from large-scale single-cell studies of the adult human cortex (<xref ref-type="bibr" rid="B50">Seidlitz et al., 2020</xref>). Cell types are divided into seven canonical classes: astrocytes, excitatory neurons, inhibitory neurons, endothelial cells, oligodendrocytes, oligodendrocyte precursors (OPs), and microglia. We overlapped the gene set of each cell type with the PLSR component 1 (PLS1) genes. A permutation test was applied to obtain the <italic>p</italic>-value of the overlapping gene number in each cell type (FDR correction, <italic>p</italic> &#x003C; 0.05). We also performed enrichment analyses in genes involved in each cell type using the Metascape tool [Benjamini&#x2013;Hochberg FDR correction (<italic>q</italic> &#x003C; 0.05)] (<xref ref-type="bibr" rid="B63">Zhou et al., 2019</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="S3">
<title>Results</title>
<sec id="S3.SS1">
<title>Demographic Characterization and Partial Least Squares Regression Analysis Results</title>
<p>The demographic characterization of the discovery dataset, validation dataset 1 and specificity dataset 1 is shown in <xref ref-type="table" rid="T1">Table 1</xref>. The demographic information of validation dataset 2 and specificity dataset 2 is shown in <xref ref-type="supplementary-material" rid="DS1">Supplementary Table 1</xref>.</p>
<p>In the discovery dataset, we identified that the 16-component model had the best fit from the initial 35 component analyses applying cross-validation. The 16-component model was used in the PLSR analysis. Components 1 and 2 interpreted greater than 10% of the variance. However, only PLS1 interpreted a remarkable ratio of the &#x0394;CT (<italic>p</italic> &#x003C; 0.001, 10,000 permutations), and it was chosen for subsequent analyses (FDR correction, <italic>q</italic> &#x003C; 0.05). The correlations of &#x0394;CT and PLS1 gene loading among the discovery dataset, validation dataset 1 and specificity dataset are shown in <xref ref-type="fig" rid="F2">Figure 2</xref>. Detailed PLSR analysis results of these three datasets are described in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Correlation of &#x0394;CT and gene loading value between the discovery, validation, and specificity datasets <bold>(A&#x2013;F)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-13-745381-g002.tif"/>
</fig>
</sec>
<sec id="S3.SS2">
<title>Gene Enrichment Results in Discovery and Validation Datasets</title>
<p>In the discovery dataset, the first GO term was &#x201C;chemical synaptic transmission&#x201D; (GO: 0007268) in upregulated genes from PLS1 (FDR correction for multiple comparisons [adjusted <italic>p</italic>-value = 0.0005; Log<sub>10</sub>(<italic>q</italic>-value) = &#x2212;20.072)]. In validation dataset 1, the first GO term was also &#x201C;chemical synaptic transmission&#x201D; (GO: 0007268) in upregulated genes. When the WGCNA method was used, the first GO term was also GO: 0007268 in upregulated genes in the discovery and validation datasets. Please see <xref ref-type="fig" rid="F3">Figure 3</xref>. However, no such consistent results were found in downregulated genes.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Gene enrichment results from PLSR and WGCNA in the discovery dataset <bold>(A,C)</bold> and the validation dataset <bold>(B,D)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-13-745381-g003.tif"/>
</fig>
<p>The upregulated genes were mainly involved in the protein&#x2013;protein interaction network, and the identified molecular complex detection (MCODE) components are shown in <xref ref-type="fig" rid="F4">Figure 4</xref>. Five MCODE components, including G alpha (i,q, and s) signaling events, chloride transmembrane transport and cell-cell junction assembly, were identified. These processes play a key role in MCI progression. We discuss this finding later in more detail.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Protein&#x2013;protein interaction network and identified MCODE components <bold>(A&#x2013;F)</bold> from PLS1 gene enrichment.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-13-745381-g004.tif"/>
</fig>
<p>Tissue-specific enrichment analysis results showed that the prefrontal lobe was the same brain region of interest in both the discovery and validation datasets (<xref ref-type="supplementary-material" rid="DS1">Supplementary Table 8</xref>). We used a gene expression dataset of the prefrontal cortex from the GEO to indirectly verify our results. Enrichment analysis results showed that the first GO term was also GO: 0007268 in upregulated genes. Detailed information is provided in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>. The biological processes involved in GO: 0007268 were extracted by QuickGO<sup><xref ref-type="fn" rid="footnote6">6</xref></sup> (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>Biological processes involved in chemical synaptic transmission from QuickGO.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-13-745381-g005.tif"/>
</fig>
</sec>
<sec id="S3.SS3">
<title>Von Economo Classification Results</title>
<p>In the discovery dataset, PLS1 genes were remarkably overexpressed in the associated cortex, limbic regions, and insular cortex (VE classes 2, 6, and 7) and underexpressed in the secondary sensory cortex and primary sensory cortex (VE classes 4 and 5) compared to a null distribution. In the validation dataset, the genes in PLS1 (also component 1) were also significantly overexpressed in VE classes 2, 6, and 7 and underexpressed in VE classes 1, 4, and 5 compared to a null distribution. The <italic>p</italic>-values for all the above results were corrected by FDR (<italic>p</italic> &#x003C; 0.01, FDR correction). Please see <xref ref-type="fig" rid="F6">Figure 6</xref> and the <xref ref-type="supplementary-material" rid="DS1">Supplementary Materials</xref>.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p>&#x0394;CT and von Economo classes of PLS1 in the discovery dataset <bold>(A,C)</bold>, and the validation dataset <bold>(B,D)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-13-745381-g006.tif"/>
</fig>
</sec>
<sec id="S3.SS4">
<title>Specificity Verification Results</title>
<p>For the PLSR analysis results, we identified 16 components that had the best fit from the initial 35 component analyses. The 16-component model was used in the PLSR analysis. Components 1 and 2 interpreted greater than 10% of the variance. Only PLS1 interpreted a remarkable ratio of the &#x0394;CT (<italic>p</italic> &#x003C; 0.001, 10,000 permutations). PLS1 was chosen for subsequent analyses (FDR correction, <italic>q</italic> &#x003C; 0.05). However, the enrichment analysis of PLS1 genes was not enriched in the GO term &#x201C;chemical synaptic transmission.&#x201D; For the WGCNA results, enrichment analysis of genes from the most correlated module (MElight green) showed a remarkable association with the GO term &#x201C;regulation of lipid metabolic process&#x201D; and was not related to the GO term &#x201C;chemical synaptic transmission.&#x201D; This result verifies that the conclusion of our study was specific to MCI.</p>
<p>There were no differentially expressed genes in specificity dataset 2. Less strict thresholds of &#x201C;<italic>p</italic> &#x003C; 0.05 (not adjusted) and |log (fold change)| &#x003E; 1&#x201D; were applied for the screening of differential mRNA expression. There were almost no differentially expressed genes (two upregulated genes and two downregulated genes) (<xref ref-type="supplementary-material" rid="DS1">Supplementary Figure 8</xref>). Therefore, we did not carry out enrichment analysis in the next step. This result still verifies that the conclusion of our study was specific to MCI.</p>
</sec>
<sec id="S3.SS5">
<title>Transcriptional Signatures of &#x0394;CT-Related Genes to Cell Types and Enrichment Analysis Results</title>
<p>A total of 189 genes in the PLS1 gene list were significantly involved in astrocytes (<italic>p</italic> = 0.0096, FDR correction), 133 genes were significantly involved in excitatory neurons (<italic>p</italic> = 0.032, FDR correction), and 119 genes were significantly involved in inhibitory neurons (<italic>p</italic> = 0.041, FDR correction), Furthermore, 100 genes involved in endothelial cells, 59 genes involved in oligodendrocytes, 34 genes involved in OPs, and 30 genes involved in microglia are not significant (<xref ref-type="fig" rid="F7">Figure 7A</xref>). Enrichment analysis results revealed that &#x0394;CT-related genes related to cell types were enriched in GO terms including &#x201C;chemical synaptic transmission,&#x201D; &#x201C;cellular component morphogenesis,&#x201D; &#x201C;cell junction organization,&#x201D; &#x201C;synaptic transmission, glutamatergic,&#x201D; and &#x201C;head development.&#x201D; <xref ref-type="fig" rid="F7">Figure 7B</xref> shows the detailed information. Together, this study identified &#x0394;CT-related gene expression in unique cell types, allowing us to ascertain specific cell types known to be associated with AD progression pathology.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption><p>&#x0394;CT-related genes (PLS1) for cell type-specific analysis in discovery dataset. <bold>(A)</bold> The number of overlapping genes for each cell type (all permutated <italic>p</italic>-values were adjusted by FDR; <bold>(B)</bold> Gene Ontology terms enriched for &#x0394;CT related PLS1 genes for each cell type.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-13-745381-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="S4">
<title>Discussion</title>
<p>Applying PLSR to a discovery dataset, we found that PLS1 explained a striking ratio of the &#x0394;CT and that the upregulated genes were remarkably enriched in the GO term &#x201C;chemical synaptic transmission.&#x201D; We validated this result using two other independent datasets and the WGCNA method instead of PLSR. Specificity verification was also conducted to verify that the conclusion of our study was MCI specific. Our study provides a stable demonstration coupling disease-related differentiation in cortical thickness with chemical synaptic transmission of transcriptionally upregulated genes from the postmortem brain cortex, thus connecting molecular pathology to macropathology. This might be the first study to combine transcriptionally upregulated gene risk mechanisms in MCI progression with variances in cortical thickness.</p>
<p>The validation using two other independent datasets suggests that our findings are robust. No remarkable correlations of &#x0394;CT between the discovery and validation datasets verified the independence of the validation dataset. We can also verify this from the significant association of gene loading values. Regarding the &#x0394;CT between MCIs with different conversion labels, we could infer that cortical thickness changes during MCI, thus predicting that some MCI patients would become AD patients in the following years. This result is consistent with our previous study (<xref ref-type="bibr" rid="B59">Wang et al., 2021</xref>). Abnormal cortical thickness could be attributed to several reasons, for example, alterations in synaptic pruning, myelination and dendritic arborization (<xref ref-type="bibr" rid="B23">Jespersen et al., 2011</xref>). The major result of this study is that transcriptionally upregulated genes with chemical synaptic transmission are related to &#x0394;CT in MCI progression.</p>
<p>Alzheimer&#x2019;s disease is considered a synaptic dysfunction disorder, where toxic oligomers will produce its major effect (<xref ref-type="bibr" rid="B7">Chen et al., 2019</xref>). A mouse model study of AD implied that synaptic loss might disturb the excitatory to inhibitory (E/I ratio) balance in pathways vulnerable to AD pathology (<xref ref-type="bibr" rid="B42">Palop et al., 2007</xref>). It is expected that chemical synaptic transmission will be an important module in the progression from MCI to AD. In this study, a major finding in the MCODE analysis was the presence of GABA receptor subunits. Some of these genes (e.g., GABRB1) have been found to be upregulated in AD (<xref ref-type="bibr" rid="B35">Limon et al., 2012</xref>), which is in agreement with the results from this study. Alterations in GABA receptors which are the main inhibitory neurotransmitter would have large functional implications, such as affecting transmembrane transport function. Similarly, upregulation of glutamatergic synapses was found in this study. <xref ref-type="bibr" rid="B5">Canas et al. (2014)</xref> detected a predominant loss of glutamatergic terminal markers in a &#x03B2;-amyloid peptide model of AD. Despite severe glutamate synaptic loss, this result would also have significant implications in excitability and activity dependent production of oligomers (<xref ref-type="bibr" rid="B8">Cirrito et al., 2005</xref>; <xref ref-type="bibr" rid="B31">Lauterborn et al., 2021</xref>). Moreover, the enrichment analysis of &#x0394;CT related genes to cell types was mainly and significantly enriched in &#x201C;chemical synaptic transmission&#x201D; and &#x201C;synaptic transmission, glutamatergic.&#x201D; Taken together, this study identified &#x0394;CT related gene expression in unique cell types, allowing us to ascertain specific cell types known to be associated with AD progression pathology. These evidences from transcriptionally upregulated genes in AD or MCI has underlined a crucial function for synaptic transmission for the pathology of this disease (<xref ref-type="bibr" rid="B37">Meng and Mei, 2019</xref>; <xref ref-type="bibr" rid="B61">Yan and Rein, 2021</xref>). Transcriptional upregulation might imply a causal risk mechanism of AD or a compensatory product of the genetic risk of AD (<xref ref-type="bibr" rid="B49">Scheff et al., 1990</xref>).</p>
<p>In this study, we were not able to determine whether transcriptionally upregulated genes causally lead to changes in CT or whether they are both downstream of a common risk mechanism. It is also likely that transcriptional upregulation and changes in CT are downstream processes of the genetic risk involved in MCI progression. It should be noted that upregulated gene transcription is not necessarily responsible for the changes in cortical thickness. However, we were able to demonstrate that changes in CT were significantly associated with chemical synaptic transmission, and this significant association only appeared during the MCI_AD transition and not during the NC_MCI transition (specificity dataset 1). This association did not appear in other subtypes of dementia, such as VaD (specificity dataset 2). Specific analyses in this study verified this result.</p>
<p>In addition to the top GO term &#x201C;chemical synaptic transmission,&#x201D; the PLS1 genes were enriched in several GO terms, such as acetylcholine-gated cation-selective channel activity, dopaminergic synaptic transmission, cell junction, cellular anatomical entity, cognition, learning or memory, and behavior. These biological processes are almost inseparable from the functions involved in the etiology of AD or MCI. We summarized the relative GO terms of chemical synaptic transmission from the QuickGO website to explain our enrichment analysis results. Accumulating evidence indicates that abnormal synaptic transmission appears in the MCI stage and is related to deficits in cognition (<xref ref-type="bibr" rid="B44">Querfurth and LaFerla, 2010</xref>). Synaptic loss also appears in a variety of transgenic animal models of AD, together with a decline in memory and learning (<xref ref-type="bibr" rid="B51">Sheng et al., 2012</xref>; <xref ref-type="bibr" rid="B15">Forner et al., 2017</xref>). <xref ref-type="bibr" rid="B40">Nistic&#x00F2; et al. (2012)</xref> reported that restoration of excitatory synaptic transmission in the hippocampus through various approaches, such as short peptide gene manipulation, and small molecules or antibodies, could effectively ameliorate cognitive deficits in animal models of AD. Our findings suggest that examining the specific role of synaptic-related genes in changing cortical morphology would facilitate clarifying the underlying molecular mechanisms of &#x0394;CT detected in MCI patients with different conversion labels, creating a new avenue for improving disease-modifying approaches to slow down or treat AD progression. Similarly, the associated pathway of chemical synaptic transmission might be a good starting point.</p>
<p>Enrichment analysis of tissue-specific genes revealed that the genes from PLS1 were enriched in the prefrontal lobe in both the discovery and validation datasets. This indicates that the prefrontal cortex is a key brain region with transcriptional abnormalities. The abnormality might be related to synaptic transmission function. <xref ref-type="bibr" rid="B45">Reddy et al. (2005)</xref> reported that compared with individuals with NC, prefrontal synaptic protein loss was more severe than parietal synaptic protein loss in AD participants, implying that the prefrontal regions might be more important for synaptic function. <xref ref-type="bibr" rid="B45">Reddy et al. (2005)</xref> also indicated that presynaptic and post-synaptic proteins are critical for synaptic function and might have a relationship with cognitive decline in AD patients. Recently, <xref ref-type="bibr" rid="B61">Yan and Rein (2021)</xref> reviewed the pathophysiological implication of the dysregulation of prefrontal synaptic transmission in AD and illustrated the underlying epigenetic mechanisms of the dysregulation of prefrontal genes and synaptic disorders in AD. Our results in AD patients are consistent with these previous findings, which established a remarkable association of cortical thickness and chemical synaptic transmission in the prefrontal lobe.</p>
<p>Protein&#x2013;protein interaction enrichment analysis showed PLS1 genes mainly involved in G alpha signaling events, chloride transmembrane transport, and cell-cell junction assembly. These pathways have been demonstrated to be related to the pathological process of AD (<xref ref-type="bibr" rid="B16">Georgakopoulos et al., 2001</xref>; <xref ref-type="bibr" rid="B57">Thathiah and De Strooper, 2011</xref>; <xref ref-type="bibr" rid="B12">Eggert et al., 2018</xref>). G-protein-coupled receptors (GPCRs) are the largest class of transmembrane receptors and a common therapeutic target (<xref ref-type="bibr" rid="B9">Dal Pr&#x00E0; et al., 2019</xref>). These studies provided attractive demonstrations and indicated that GPCRs may have a role in the etiopathogenesis of AD and in many stages of amyloid precursor protein (APP) proteolysis. <xref ref-type="bibr" rid="B10">Deyts et al. (2019)</xref> revealed that APP-mediated signaling through a direct interaction with the G-protein alpha subunit prevents memory and cognitive decline in an AD mouse model. Recently, <xref ref-type="bibr" rid="B3">Bose et al. (2021)</xref> reported that dysfunction of endosomal and lysosomal CLC chloride transporters results in neurodegeneration in mice and humans. Cell-cell junctions have been shown to be related to the AD-related presenilin 1 gene (<xref ref-type="bibr" rid="B54">Singh et al., 2001</xref>). In addition, all three protein functions are targets for FDA-approved small molecule drugs. Again, these previous studies imply the significance of our results.</p>
<p>Spatial profiling showed that PLS1 genes were remarkably overexpressed in the insular cortex, association cortex and limbic regions and underexpressed in the secondary sensory cortex and primary sensory cortex in both the discovery and validation datasets. The association cortex receives multichannel information and connects neural activities in various functional specific areas. A very early study demonstrated that a set of complex visual discrepancies may result from known neuropathology in the visual association cortex in patients with AD (<xref ref-type="bibr" rid="B36">Mendez et al., 1990</xref>). Notably, insular cortex atrophy is related to neurological phenotypes in AD (<xref ref-type="bibr" rid="B38">Moon et al., 2014</xref>). Recently, a meta-analysis of genetic transcription data emphasized hippocampal synaptic abnormalities in the AD brain (<xref ref-type="bibr" rid="B21">Hosseinian et al., 2020</xref>). Similarly, there is evidence that the secondary and primary sensory cortices are closely related to the etiology of AD (<xref ref-type="bibr" rid="B20">Hof and Morrison, 1990</xref>).</p>
<p>The limitations of this study cannot be ignored. First, gene transcriptional data were evaluated from only six postmortem adult brain samples, although these types of samples are widely used (<xref ref-type="bibr" rid="B1">Anderson et al., 2018</xref>; <xref ref-type="bibr" rid="B47">Romero-Garcia et al., 2019</xref>). However, the six adult brain samples were the most spatially detailed gene expression data. Moreover, these data have Montreal Neurological Institute (MNI) coordinates that could map adult brain gene expression to &#x0394;CT. Gene enrichment results related to MCI pathogenesis provide further support for the findings. Second, in this work, we assessed cortical thickness rather than other brain characteristics, such as cortical volume. The combination of the effects of at least two different genetic sources on brain volume would have complicated a significant analysis of the relevant genetic weights. Third, neuronal loss was a factor in the analysis. A very early study showed that neuronal loss correlates with but exceeds neurofibrillary tangles in AD (<xref ref-type="bibr" rid="B17">G&#x00F3;mez-Isla et al., 1997</xref>). <xref ref-type="bibr" rid="B41">Nobili et al. (2017)</xref> demonstrated that dopamine neuronal loss contributes to memory and reward dysfunction in a model of AD (<xref ref-type="bibr" rid="B41">Nobili et al., 2017</xref>). Exploring the associations among neuronal loss, transcriptional level, and abnormal brain cortical morphology is a valuable topic. Fourth, different MCI conversion dates are also a limitation. Finally, the MCI_S group and NC_S group were the same with MCI_S in the validation dataset and NC_S in the specificity dataset (<xref ref-type="table" rid="T1">Table 1</xref>). The reasons of using the same group is that the MCI_S and NC_S groups are both the control group and to avoid introducing distractions. <xref ref-type="bibr" rid="B47">Romero-Garcia et al. (2019)</xref> also used the same control group for both the Autism Discovery and the ADHD datasets. The experimental groups are mutually independent among the three datasets, which is appropriate to validate our findings to a certain degree.</p>
</sec>
<sec sec-type="data-availability" id="S5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="supplementary-material" rid="DS1">Supplementary Material</xref>.</p>
</sec>
<sec id="S6">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by we confirm that all procedures performed in this study involving human participants were in accordance with the ethical standards of the ADNI consortium Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants or surrogates (<ext-link ext-link-type="uri" xlink:href="http://adni.loni.usc.edu">adni.loni.usc.edu</ext-link>). The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s), and minor(s)&#x2019; legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="S7">
<title>Author Contributions</title>
<p>SC wrote the first draft of the manuscript. KH and FY prepared the material. XW and SW performed the data acquisition and analysis. YW and LH performed the repeated revisions of the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="S13">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="S12">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (grant nos. 81801789 and 81671778), the China Postdoctoral Science Foundation (grant no. 2017M623128), the National Natural Science Foundation of Shaanxi of China (grant no. 2020JM-212), and the Fundamental Research Funds for the Central Universities (grant no. XJS201203).</p>
</sec>
<sec id="S9" sec-type="supplementary material"><title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnagi.2021.745381/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnagi.2021.745381/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="DS1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_2.zip" id="DS2" mimetype="application/zip" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_1.xlsx" id="TS1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.xlsx" id="TS2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>K. M.</given-names></name> <name><surname>Krienen</surname> <given-names>F. M.</given-names></name> <name><surname>Choi</surname> <given-names>E. Y.</given-names></name> <name><surname>Reinen</surname> <given-names>J. M.</given-names></name> <name><surname>Yeo</surname> <given-names>B. T.</given-names></name> <name><surname>Holmes</surname> <given-names>A. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Gene expression links functional networks across cortex and striatum.</article-title> <source><italic>Nat. commun.</italic></source> <volume>9</volume> <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-03811-x</pub-id> <pub-id pub-id-type="pmid">29651138</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berchtold</surname> <given-names>N. C.</given-names></name> <name><surname>Coleman</surname> <given-names>P. D.</given-names></name> <name><surname>Cribbs</surname> <given-names>D. H.</given-names></name> <name><surname>Rogers</surname> <given-names>J.</given-names></name> <name><surname>Gillen</surname> <given-names>D. L.</given-names></name> <name><surname>Cotman</surname> <given-names>C. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer&#x2019;s disease.</article-title> <source><italic>Neurobiol. Aging</italic></source> <volume>34</volume> <fpage>1653</fpage>&#x2013;<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.11.024</pub-id> <pub-id pub-id-type="pmid">23273601</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname> <given-names>S.</given-names></name> <name><surname>He</surname> <given-names>H.</given-names></name> <name><surname>Stauber</surname> <given-names>T.</given-names></name></person-group> (<year>2021</year>). <article-title>Neurodegeneration upon dysfunction of endosomal/lysosomal CLC chloride transporters.</article-title> <source><italic>Front. Cell Dev. Biol.</italic></source> <volume>9</volume>:<issue>323</issue>. <pub-id pub-id-type="doi">10.3389/fcell.2021.639231</pub-id> <pub-id pub-id-type="pmid">33708769</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bottero</surname> <given-names>V.</given-names></name> <name><surname>Potashkin</surname> <given-names>J. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Meta-analysis of gene expression changes in the blood of patients with mild cognitive impairment and alzheimer&#x2019;s disease dementia.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>20</volume>:<issue>5403</issue>. <pub-id pub-id-type="doi">10.3390/ijms20215403</pub-id> <pub-id pub-id-type="pmid">31671574</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Canas</surname> <given-names>P. M.</given-names></name> <name><surname>Sim&#x00F5;es</surname> <given-names>A. P.</given-names></name> <name><surname>Rodrigues</surname> <given-names>R. J.</given-names></name> <name><surname>Cunha</surname> <given-names>R. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Predominant loss of glutamatergic terminal markers in a &#x03B2;-amyloid peptide model of Alzheimer&#x2019;s disease.</article-title> <source><italic>Neuropharmacology</italic></source> <volume>76</volume> <fpage>51</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.08.026</pub-id> <pub-id pub-id-type="pmid">24029236</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>E. Y.</given-names></name> <name><surname>Tan</surname> <given-names>C. M.</given-names></name> <name><surname>Kou</surname> <given-names>Y.</given-names></name> <name><surname>Duan</surname> <given-names>Q.</given-names></name> <name><surname>Ayan</surname> <given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.</article-title> <source><italic>BMC Bioinform.</italic></source> <volume>14</volume>:<issue>128</issue>. <pub-id pub-id-type="doi">10.1186/1471-2105-14-128</pub-id> <pub-id pub-id-type="pmid">23586463</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Fu</surname> <given-names>A. K.</given-names></name> <name><surname>Ip</surname> <given-names>N. Y.</given-names></name></person-group> (<year>2019</year>). <article-title>Synaptic dysfunction in Alzheimer&#x2019;s disease: mechanisms and therapeutic strategies.</article-title> <source><italic>Pharmacol. Therap.</italic></source> <volume>195</volume> <fpage>186</fpage>&#x2013;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2018.11.006</pub-id> <pub-id pub-id-type="pmid">30439458</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cirrito</surname> <given-names>J. R.</given-names></name> <name><surname>Yamada</surname> <given-names>K. A.</given-names></name> <name><surname>Finn</surname> <given-names>M. B.</given-names></name> <name><surname>Sloviter</surname> <given-names>R. S.</given-names></name> <name><surname>Bales</surname> <given-names>K. R.</given-names></name> <name><surname>May</surname> <given-names>P. C.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Synaptic activity regulates interstitial fluid amyloid-&#x03B2; levels in vivo.</article-title> <source><italic>Neuron</italic></source> <volume>48</volume> <fpage>913</fpage>&#x2013;<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.10.028</pub-id> <pub-id pub-id-type="pmid">16364896</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dal Pr&#x00E0;</surname> <given-names>I.</given-names></name> <name><surname>Armato</surname> <given-names>U.</given-names></name> <name><surname>Chiarini</surname> <given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Family C G-protein-coupled receptors in Alzheimer&#x2019;s disease and therapeutic implications.</article-title> <source><italic>Front. Pharmacol.</italic></source> <volume>10</volume>:<issue>1282</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2019.01282</pub-id> <pub-id pub-id-type="pmid">31719824</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deyts</surname> <given-names>C.</given-names></name> <name><surname>Clutter</surname> <given-names>M.</given-names></name> <name><surname>Pierce</surname> <given-names>N.</given-names></name> <name><surname>Chakrabarty</surname> <given-names>P.</given-names></name> <name><surname>Ladd</surname> <given-names>T. B.</given-names></name> <name><surname>Goddi</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>APP-mediated signaling prevents memory decline in Alzheimer&#x2019;s disease mouse model.</article-title> <source><italic>Cell Rep.</italic></source> <volume>27</volume> <fpage>1345</fpage>&#x2013;<lpage>1355</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.03.087</pub-id> <pub-id pub-id-type="pmid">31042463</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Economo</surname> <given-names>C. V.</given-names></name> <name><surname>Koskinas</surname> <given-names>G. N.</given-names></name> <name><surname>Triarhou</surname> <given-names>L. C.</given-names></name></person-group> (<year>2008</year>). <source><italic>Atlas of Cytoarchitectonics of the Adult Human Cerebral Cortex.</italic></source> <publisher-loc>Shenzhen</publisher-loc>: <publisher-name>Kanger International</publisher-name>.</citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eggert</surname> <given-names>S.</given-names></name> <name><surname>Thomas</surname> <given-names>C.</given-names></name> <name><surname>Kins</surname> <given-names>S.</given-names></name> <name><surname>Hermey</surname> <given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Trafficking in Alzheimer&#x2019;s disease: modulation of APP transport and processing by the transmembrane proteins LRP1, SorLA, SorCS1c, Sortilin, and Calsyntenin.</article-title> <source><italic>Mol. Neurobiol.</italic></source> <volume>55</volume> <fpage>5809</fpage>&#x2013;<lpage>5829</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-017-0806-x</pub-id> <pub-id pub-id-type="pmid">29079999</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filippi</surname> <given-names>M.</given-names></name> <name><surname>Basaia</surname> <given-names>S.</given-names></name> <name><surname>Canu</surname> <given-names>E.</given-names></name> <name><surname>Imperiale</surname> <given-names>F.</given-names></name> <name><surname>Magnani</surname> <given-names>G.</given-names></name> <name><surname>Falautano</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Changes in functional and structural brain connectome along the Alzheimer&#x2019;s disease continuum.</article-title> <source><italic>Mol. Psychiatry</italic></source> <volume>25</volume> <fpage>230</fpage>&#x2013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-018-0067-8</pub-id> <pub-id pub-id-type="pmid">29743583</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischl</surname> <given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>FreeSurfer.</article-title> <source><italic>Neuroimage</italic></source> <volume>62</volume> <fpage>774</fpage>&#x2013;<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.01.021</pub-id> <pub-id pub-id-type="pmid">22248573</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forner</surname> <given-names>S.</given-names></name> <name><surname>Baglietto-Vargas</surname> <given-names>D.</given-names></name> <name><surname>Martini</surname> <given-names>A. C.</given-names></name> <name><surname>Trujillo-Estrada</surname> <given-names>L.</given-names></name> <name><surname>Laferla</surname> <given-names>F. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Synaptic impairment in Alzheimer&#x2019;s disease: a dysregulated symphony.</article-title> <source><italic>Trends Neurosci.</italic></source> <volume>40</volume> <fpage>347</fpage>&#x2013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2017.04.002</pub-id> <pub-id pub-id-type="pmid">28494972</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georgakopoulos</surname> <given-names>A.</given-names></name> <name><surname>Marambaud</surname> <given-names>P.</given-names></name> <name><surname>Robakis</surname> <given-names>N. K.</given-names></name> <name><surname>Baki</surname> <given-names>L.</given-names></name></person-group> (<year>2001</year>). <article-title>Presenilin&#x2212;1 is a regulatory component of the cadherin cell adhesion complex: implications for alzheimer&#x2019;s disease.</article-title> <source><italic>Alzheimer&#x2019;s Dis.</italic></source> <volume>2001</volume> <fpage>521</fpage>&#x2013;<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1002/0470846453.ch48</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>G&#x00F3;mez-Isla</surname> <given-names>T.</given-names></name> <name><surname>Hollister</surname> <given-names>R.</given-names></name> <name><surname>West</surname> <given-names>H.</given-names></name> <name><surname>Mui</surname> <given-names>S.</given-names></name> <name><surname>Growdon</surname> <given-names>J. H.</given-names></name> <name><surname>Petersen</surname> <given-names>R. C.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer&#x2019;s disease.</article-title> <source><italic>Ann. Neurol.</italic></source> <volume>41</volume> <fpage>17</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410410106</pub-id> <pub-id pub-id-type="pmid">9005861</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawrylycz</surname> <given-names>M.</given-names></name> <name><surname>Miller</surname> <given-names>J. A.</given-names></name> <name><surname>Menon</surname> <given-names>V.</given-names></name> <name><surname>Feng</surname> <given-names>D.</given-names></name> <name><surname>Dolbeare</surname> <given-names>T.</given-names></name> <name><surname>Guillozet-Bongaarts</surname> <given-names>A. L.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Canonical genetic signatures of the adult human brain.</article-title> <source><italic>Nat. Neurosci.</italic></source> <volume>18</volume>:<issue>1832</issue>. <pub-id pub-id-type="doi">10.1038/nn.4171</pub-id> <pub-id pub-id-type="pmid">26571460</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawrylycz</surname> <given-names>M. J.</given-names></name> <name><surname>Lein</surname> <given-names>E. S.</given-names></name> <name><surname>Guillozet-Bongaarts</surname> <given-names>A. L.</given-names></name> <name><surname>Shen</surname> <given-names>E. H.</given-names></name> <name><surname>Ng</surname> <given-names>L.</given-names></name> <name><surname>Miller</surname> <given-names>J. A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>An anatomically comprehensive atlas of the adult human brain transcriptome.</article-title> <source><italic>Nature</italic></source> <volume>489</volume> <fpage>391</fpage>&#x2013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1038/nature11405</pub-id> <pub-id pub-id-type="pmid">22996553</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hof</surname> <given-names>P. R.</given-names></name> <name><surname>Morrison</surname> <given-names>J. H.</given-names></name></person-group> (<year>1990</year>). <article-title>Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer&#x2019;s disease: II. Primary and secondary visual cortex.</article-title> <source><italic>J. Compar. Neurol.</italic></source> <volume>301</volume> <fpage>55</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903010106</pub-id> <pub-id pub-id-type="pmid">1706358</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hosseinian</surname> <given-names>S.</given-names></name> <name><surname>Arefian</surname> <given-names>E.</given-names></name> <name><surname>Rakhsh-Khorshid</surname> <given-names>H.</given-names></name> <name><surname>Eivani</surname> <given-names>M.</given-names></name> <name><surname>Rezayof</surname> <given-names>A.</given-names></name> <name><surname>Pezeshk</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A meta-analysis of gene expression data highlights synaptic dysfunction in the hippocampus of brains with Alzheimer&#x2019;s disease.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>10</volume> <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-64452-z</pub-id> <pub-id pub-id-type="pmid">32433480</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname> <given-names>I. E.</given-names></name> <name><surname>Savage</surname> <given-names>J. E.</given-names></name> <name><surname>Watanabe</surname> <given-names>K.</given-names></name> <name><surname>Bryois</surname> <given-names>J.</given-names></name> <name><surname>Williams</surname> <given-names>D. M.</given-names></name> <name><surname>Steinberg</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk.</article-title> <source><italic>Nat. Genet.</italic></source> <volume>51</volume> <fpage>404</fpage>&#x2013;<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0311-9</pub-id> <pub-id pub-id-type="pmid">30617256</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jespersen</surname> <given-names>S. N.</given-names></name> <name><surname>Leigland</surname> <given-names>L. A.</given-names></name> <name><surname>Cornea</surname> <given-names>A.</given-names></name> <name><surname>Kroenke</surname> <given-names>C. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Determination of axonal and dendritic orientation distributions within the developing cerebral cortex by diffusion tensor imaging.</article-title> <source><italic>IEEE Trans. Med. Imag.</italic></source> <volume>31</volume> <fpage>16</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1109/TMI.2011.2162099</pub-id> <pub-id pub-id-type="pmid">21768045</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Julkunen</surname> <given-names>V.</given-names></name> <name><surname>Niskanen</surname> <given-names>E.</given-names></name> <name><surname>Koikkalainen</surname> <given-names>J.</given-names></name> <name><surname>Herukka</surname> <given-names>S.-K.</given-names></name> <name><surname>Pihlajam&#x00E4;ki</surname> <given-names>M.</given-names></name> <name><surname>Hallikainen</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer&#x2019;s disease patients: a longitudinal study.</article-title> <source><italic>J. Alzheimer&#x2019;s Dis.</italic></source> <volume>21</volume> <fpage>1141</fpage>&#x2013;<lpage>1151</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-100114</pub-id> <pub-id pub-id-type="pmid">21504134</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Julkunen</surname> <given-names>V.</given-names></name> <name><surname>Niskanen</surname> <given-names>E.</given-names></name> <name><surname>Muehlboeck</surname> <given-names>S.</given-names></name> <name><surname>Pihlajamaki</surname> <given-names>M.</given-names></name> <name><surname>Kononen</surname> <given-names>M.</given-names></name> <name><surname>Hallikainen</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Cortical thickness analysis to detect progressive mild cognitive impairment: a reference to Alzheimer&#x2019;s disease.</article-title> <source><italic>Dement. Geriat. Cogn. Disord.</italic></source> <volume>28</volume> <fpage>389</fpage>&#x2013;<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1159/000256274</pub-id> <pub-id pub-id-type="pmid">19907176</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuleshov</surname> <given-names>M. V.</given-names></name> <name><surname>Jones</surname> <given-names>M. R.</given-names></name> <name><surname>Rouillard</surname> <given-names>A. D.</given-names></name> <name><surname>Fernandez</surname> <given-names>N. F.</given-names></name> <name><surname>Duan</surname> <given-names>Q.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.</article-title> <source><italic>Nucleic Acids Res.</italic></source> <volume>2016</volume> <fpage>W90</fpage>&#x2013;<lpage>W97</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id> <pub-id pub-id-type="pmid">27141961</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunkle</surname> <given-names>B. W.</given-names></name> <name><surname>Grenier-Boley</surname> <given-names>B.</given-names></name> <name><surname>Sims</surname> <given-names>R.</given-names></name> <name><surname>Bis</surname> <given-names>J. C.</given-names></name> <name><surname>Damotte</surname> <given-names>V.</given-names></name> <name><surname>Naj</surname> <given-names>A. C.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates A&#x03B2;, tau, immunity and lipid processing.</article-title> <source><italic>Nat. Genet.</italic></source> <volume>51</volume> <fpage>414</fpage>&#x2013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-019-0358-2</pub-id> <pub-id pub-id-type="pmid">30820047</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lacour</surname> <given-names>E.</given-names></name> <name><surname>Louwersheimer</surname> <given-names>H.</given-names></name> <name><surname>Hernandez</surname> <given-names>W.</given-names></name> <name><surname>Fernandez</surname> <given-names>W.</given-names></name> <name><surname>Rosende-Roca</surname></name></person-group> <collab>Mauleon.</collab> (<year>2017</year>). <article-title>Genome-wide significant risk factors for Alzheimer&#x2019;s disease: role in progression to dementia due to Alzheimer&#x2019;s disease among subjects with mild cognitive impairment.</article-title> <source><italic>Mol. Psychiatry</italic></source> <volume>22</volume>:<issue>153-160</issue> <pub-id pub-id-type="doi">10.1038/mp.2016.18</pub-id> <pub-id pub-id-type="pmid">26976043</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname> <given-names>J. C.</given-names></name> <name><surname>Ibrahimverbaas</surname> <given-names>C. A.</given-names></name> <name><surname>Harold</surname> <given-names>D.</given-names></name> <name><surname>Naj</surname> <given-names>A. C.</given-names></name> <name><surname>Sims</surname> <given-names>R.</given-names></name> <name><surname>Bellenguez</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#x2019;s disease.</article-title> <source><italic>Alzheimers Demen.</italic></source> <volume>9</volume>:<issue>123</issue>. <pub-id pub-id-type="doi">10.1016/j.jalz.2013.04.040</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname> <given-names>P.</given-names></name> <name><surname>Horvath</surname> <given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>WGCNA: an R package for weighted correlation network analysis.</article-title> <source><italic>BMC Bioinform.</italic></source> <volume>9</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id> <pub-id pub-id-type="pmid">19114008</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauterborn</surname> <given-names>J. C.</given-names></name> <name><surname>Scaduto</surname> <given-names>P.</given-names></name> <name><surname>Cox</surname> <given-names>C. D.</given-names></name> <name><surname>Schulmann</surname> <given-names>A.</given-names></name> <name><surname>Lynch</surname> <given-names>G.</given-names></name> <name><surname>Gall</surname> <given-names>C. M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer&#x2019;s disease.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>12</volume> <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-22742-8</pub-id> <pub-id pub-id-type="pmid">33972518</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lerch</surname> <given-names>J. P.</given-names></name> <name><surname>Pruessner</surname> <given-names>J. C.</given-names></name> <name><surname>Zijdenbos</surname> <given-names>A.</given-names></name> <name><surname>Hampel</surname> <given-names>H.</given-names></name> <name><surname>Teipel</surname> <given-names>S. J.</given-names></name> <name><surname>Evans</surname> <given-names>A. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Focal decline of cortical thickness in Alzheimer&#x2019;s disease identified by computational neuroanatomy.</article-title> <source><italic>Cereb. Cortex</italic></source> <volume>15</volume> <fpage>995</fpage>&#x2013;<lpage>1001</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhh200</pub-id> <pub-id pub-id-type="pmid">15537673</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Jian</surname> <given-names>W.</given-names></name> <name><surname>Li</surname> <given-names>G.</given-names></name> <name><surname>Jian</surname> <given-names>Z.</given-names></name> <name><surname>Du</surname> <given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Alterations of whole-brain cortical area and thickness in mild cognitive impairment and alzheimer&#x2019;s disease.</article-title> <source><italic>J. Alzheimers Dis.</italic></source> <volume>27</volume> <fpage>281</fpage>&#x2013;<lpage>290</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2011-110497</pub-id> <pub-id pub-id-type="pmid">21799248</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Seidlitz</surname> <given-names>J.</given-names></name> <name><surname>Suckling</surname> <given-names>J.</given-names></name> <name><surname>Fan</surname> <given-names>F.</given-names></name> <name><surname>Ji</surname> <given-names>G.-J.</given-names></name> <name><surname>Meng</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Cortical structural differences in major depressive disorder correlate with cell type-specific transcriptional signatures.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>12</volume> <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-21943-5</pub-id> <pub-id pub-id-type="pmid">33712584</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Limon</surname> <given-names>A.</given-names></name> <name><surname>Reyes-Ruiz</surname> <given-names>J. M.</given-names></name> <name><surname>Miledi</surname> <given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Loss of functional GABAA receptors in the Alzheimer diseased brain.</article-title> <source><italic>Proc. Nat. Acad. Sci.</italic></source> <volume>109</volume> <fpage>10071</fpage>&#x2013;<lpage>10076</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1204606109</pub-id> <pub-id pub-id-type="pmid">22691495</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendez</surname> <given-names>M. F.</given-names></name> <name><surname>Mendez</surname> <given-names>M. A.</given-names></name> <name><surname>Martin</surname> <given-names>R.</given-names></name> <name><surname>Smyth</surname> <given-names>K. A.</given-names></name> <name><surname>Whitehouse</surname> <given-names>P. J.</given-names></name></person-group> (<year>1990</year>). <article-title>Complex visual disturbances in Alzheimer&#x2019;s disease.</article-title> <source><italic>Neurology</italic></source> <volume>40</volume> <fpage>439</fpage>&#x2013;<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.40.3_Part_1.439</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>G.</given-names></name> <name><surname>Mei</surname> <given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Transcriptional dysregulation study reveals a core network involving the progression of Alzheimer&#x2019;s disease.</article-title> <source><italic>Front. Aging Neurosci.</italic></source> <volume>11</volume>:<issue>101</issue>. <pub-id pub-id-type="doi">10.3389/fnagi.2019.00101</pub-id> <pub-id pub-id-type="pmid">31133844</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname> <given-names>Y.</given-names></name> <name><surname>Moon</surname> <given-names>W.-J.</given-names></name> <name><surname>Kim</surname> <given-names>H.</given-names></name> <name><surname>Han</surname> <given-names>S.-H.</given-names></name></person-group> (<year>2014</year>). <article-title>Regional atrophy of the insular cortex is associated with neuropsychiatric symptoms in Alzheimer&#x2019;s disease patients.</article-title> <source><italic>Eur. Neurol.</italic></source> <volume>71</volume> <fpage>223</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1159/000356343</pub-id> <pub-id pub-id-type="pmid">24480815</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>J. C.</given-names></name> <name><surname>Price</surname> <given-names>J. L.</given-names></name></person-group> (<year>2001</year>). <article-title>Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer&#x2019;s disease.</article-title> <source><italic>J. Mol. Neurosci.</italic></source> <volume>17</volume>:<issue>101</issue>. <pub-id pub-id-type="doi">10.1385/JMN:17:2:101</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nistic&#x00F2;</surname> <given-names>R.</given-names></name> <name><surname>Pignatelli</surname> <given-names>M.</given-names></name> <name><surname>Piccinin</surname> <given-names>S.</given-names></name> <name><surname>Mercuri</surname> <given-names>N. B.</given-names></name> <name><surname>Collingridge</surname> <given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Targeting synaptic dysfunction in Alzheimer&#x2019;s disease therapy.</article-title> <source><italic>Mol. Neurobiol.</italic></source> <volume>46</volume> <fpage>572</fpage>&#x2013;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-012-8324-3</pub-id> <pub-id pub-id-type="pmid">22914888</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nobili</surname> <given-names>A.</given-names></name> <name><surname>Latagliata</surname> <given-names>E. C.</given-names></name> <name><surname>Viscomi</surname> <given-names>M. T.</given-names></name> <name><surname>Cavallucci</surname> <given-names>V.</given-names></name> <name><surname>Cutuli</surname> <given-names>D.</given-names></name> <name><surname>Giacovazzo</surname> <given-names>G.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer&#x2019;s disease.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>8</volume> <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms14727</pub-id> <pub-id pub-id-type="pmid">28367951</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palop</surname> <given-names>J. J.</given-names></name> <name><surname>Chin</surname> <given-names>J.</given-names></name> <name><surname>Roberson</surname> <given-names>E. D.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Thwin</surname> <given-names>M. T.</given-names></name> <name><surname>Bien-Ly</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer&#x2019;s disease.</article-title> <source><italic>Neuron</italic></source> <volume>55</volume> <fpage>697</fpage>&#x2013;<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.025</pub-id> <pub-id pub-id-type="pmid">17785178</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Querbes</surname> <given-names>O.</given-names></name> <name><surname>Aubry</surname> <given-names>F.</given-names></name> <name><surname>Pariente</surname> <given-names>J.</given-names></name> <name><surname>Lotterie</surname> <given-names>J.-A.</given-names></name> <name><surname>D&#x00E9;monet</surname> <given-names>J.-F.</given-names></name> <name><surname>Duret</surname> <given-names>V.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Early diagnosis of Alzheimer&#x2019;s disease using cortical thickness: impact of cognitive reserve.</article-title> <source><italic>Brain</italic></source> <volume>132</volume> <fpage>2036</fpage>&#x2013;<lpage>2047</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp105</pub-id> <pub-id pub-id-type="pmid">19439419</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Querfurth</surname> <given-names>H.</given-names></name> <name><surname>LaFerla</surname> <given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>Alzheimer&#x2019;s disease.</article-title> <source><italic>N. Engl. J. Med.</italic></source> <volume>362</volume> <fpage>1844</fpage>&#x2013;<lpage>1845</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra0909142</pub-id> <pub-id pub-id-type="pmid">20107219</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname> <given-names>P. H.</given-names></name> <name><surname>Mani</surname> <given-names>G.</given-names></name> <name><surname>Park</surname> <given-names>B. S.</given-names></name> <name><surname>Jacques</surname> <given-names>J.</given-names></name> <name><surname>Murdoch</surname> <given-names>G.</given-names></name> <name><surname>Whetsell</surname> <suffix>Jr.</suffix></name><etal/></person-group> (<year>2005</year>). <article-title>Differential loss of synaptic proteins in Alzheimer&#x2019;s disease: implications for synaptic dysfunction.</article-title> <source><italic>J. Alzheimer&#x2019;s Dis.</italic></source> <volume>7</volume> <fpage>103</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2005-7203</pub-id> <pub-id pub-id-type="pmid">15851848</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romero-Garcia</surname> <given-names>R.</given-names></name> <name><surname>Seidlitz</surname> <given-names>J.</given-names></name> <name><surname>Whitaker</surname> <given-names>K. J.</given-names></name> <name><surname>Morgan</surname> <given-names>S. E.</given-names></name> <name><surname>Fonagy</surname> <given-names>P.</given-names></name> <name><surname>Dolan</surname> <given-names>R. J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Schizotypy-related magnetization of cortex in healthy adolescence is colocated with expression of schizophrenia-related genes.</article-title> <source><italic>Biol. Psychiatry</italic></source> <volume>88</volume> <fpage>248</fpage>&#x2013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2019.12.005</pub-id> <pub-id pub-id-type="pmid">32029217</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romero-Garcia</surname> <given-names>R.</given-names></name> <name><surname>Warrier</surname> <given-names>V.</given-names></name> <name><surname>Bullmore</surname> <given-names>E. T.</given-names></name> <name><surname>Baron-Cohen</surname> <given-names>S.</given-names></name> <name><surname>Bethlehem</surname> <given-names>R. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Synaptic and transcriptionally downregulated genes are associated with cortical thickness differences in autism.</article-title> <source><italic>Mol. Psychiatry</italic></source> <volume>24</volume> <fpage>1053</fpage>&#x2013;<lpage>1064</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-018-0023-7</pub-id> <pub-id pub-id-type="pmid">29483624</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romero-Garcia</surname> <given-names>R.</given-names></name> <name><surname>Whitaker</surname> <given-names>K. J.</given-names></name> <name><surname>Seidlitz</surname> <given-names>J.</given-names></name> <name><surname>Shinn</surname> <given-names>M.</given-names></name> <name><surname>Fonagy</surname> <given-names>P.</given-names></name> <name><surname>Dolan</surname> <given-names>R. J.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Structural covariance networks are coupled to expression of genes enriched in supragranular layers of the human cortex.</article-title> <source><italic>Neuroimage</italic></source> <volume>2018</volume>:<issue>844</issue>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.12.060</pub-id> <pub-id pub-id-type="pmid">29274746</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheff</surname> <given-names>S. W.</given-names></name> <name><surname>Dekosky</surname> <given-names>S. T.</given-names></name> <name><surname>Price</surname> <given-names>D. A.</given-names></name></person-group> (<year>1990</year>). <article-title>Quantitative assessment of cortical synaptic density in Alzheimer&#x2019;s disease.</article-title> <source><italic>Neurobiol. Aging</italic></source> <volume>11</volume> <fpage>29</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/0197-4580(90)90059-9</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seidlitz</surname> <given-names>J.</given-names></name> <name><surname>Nadig</surname> <given-names>A.</given-names></name> <name><surname>Liu</surname> <given-names>S.</given-names></name> <name><surname>Bethlehem</surname> <given-names>R. A.</given-names></name> <name><surname>Vertes</surname> <given-names>P. E.</given-names></name> <name><surname>Morgan</surname> <given-names>S. E.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>11</volume> <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-17051-5</pub-id> <pub-id pub-id-type="pmid">32620757</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>M.</given-names></name> <name><surname>Sabatini</surname> <given-names>B. L.</given-names></name> <name><surname>S&#x00FC;dhof</surname> <given-names>T. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Synapses and Alzheimer&#x2019;s disease.</article-title> <source><italic>Cold Spr. Harbor Persp. Biol.</italic></source> <volume>4</volume>:<issue>a005777</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a005777</pub-id> <pub-id pub-id-type="pmid">22491782</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shirotani</surname> <given-names>K.</given-names></name> <name><surname>Asai</surname> <given-names>M.</given-names></name> <name><surname>Iwata</surname> <given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Paradigm shift from diagnosing patients based on common symptoms to categorizing patients into subtypes with different pathogenic mechanisms to guide treatment for Alzheimer&#x2019;s disease.</article-title> <source><italic>J. Biochem.</italic></source> <volume>161</volume> <fpage>463</fpage>&#x2013;<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1093/jb/mvx015</pub-id> <pub-id pub-id-type="pmid">28338847</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname> <given-names>R.</given-names></name> <name><surname>Van Der Lee</surname> <given-names>S. J.</given-names></name> <name><surname>Naj</surname> <given-names>A. C.</given-names></name> <name><surname>Bellenguez</surname> <given-names>C.</given-names></name> <name><surname>Badarinarayan</surname> <given-names>N.</given-names></name> <name><surname>Jakobsdottir</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer&#x2019;s disease.</article-title> <source><italic>Nat. Genet.</italic></source> <volume>49</volume> <fpage>1373</fpage>&#x2013;<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3916</pub-id> <pub-id pub-id-type="pmid">28714976</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>N.</given-names></name> <name><surname>Talalayeva</surname> <given-names>Y.</given-names></name> <name><surname>Tsiper</surname> <given-names>M.</given-names></name> <name><surname>Romanov</surname> <given-names>V.</given-names></name> <name><surname>Dranovsky</surname> <given-names>A.</given-names></name> <name><surname>Colflesh</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>The role of Alzheimer&#x2019;s disease-related presenilin 1 in intercellular adhesion.</article-title> <source><italic>Experim. Cell Res.</italic></source> <volume>263</volume> <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1006/excr.2000.5098</pub-id> <pub-id pub-id-type="pmid">11161700</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stephan</surname> <given-names>B. C. M.</given-names></name> <name><surname>Hunter</surname> <given-names>S.</given-names></name> <name><surname>Harris</surname> <given-names>D.</given-names></name> <name><surname>Llewellyn</surname> <given-names>D. J.</given-names></name> <name><surname>Siervo</surname> <given-names>M.</given-names></name> <name><surname>Matthews</surname> <given-names>F. E.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The neuropathological profile of mild cognitive impairment (MCI): a systematic review.</article-title> <source><italic>Mol. Psychiatry</italic></source> <volume>17</volume> <fpage>1056</fpage>&#x2013;<lpage>1076</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2011.147</pub-id> <pub-id pub-id-type="pmid">22143004</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tasaki</surname> <given-names>S.</given-names></name> <name><surname>Gaiteri</surname> <given-names>C.</given-names></name> <name><surname>Mostafavi</surname> <given-names>S.</given-names></name> <name><surname>De Jager</surname> <given-names>P. L.</given-names></name> <name><surname>Bennett</surname> <given-names>D. A.</given-names></name></person-group> (<year>2018</year>). <article-title>The molecular and neuropathological consequences of genetic risk for Alzheimer&#x2019;s dementia.</article-title> <source><italic>Front. Neurosci.</italic></source> <volume>12</volume>:<issue>699</issue>.</citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thathiah</surname> <given-names>A.</given-names></name> <name><surname>De Strooper</surname> <given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of G protein-coupled receptors in the pathology of Alzheimer&#x2019;s disease.</article-title> <source><italic>Nat. Rev. Neurosci.</italic></source> <volume>12</volume> <fpage>73</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2977</pub-id> <pub-id pub-id-type="pmid">21248787</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tobias</surname> <given-names>R. D.</given-names></name></person-group> (<year>1995</year>). &#x201C;<article-title>An introduction to partial least squares regression</article-title>,&#x201D; in <source><italic>Proceedings of the twentieth annual SAS users group international conference: Citeseer</italic></source>, (<publisher-loc>Cary, NC</publisher-loc>: <publisher-name>SAS Institute Inc</publisher-name>).</citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Huang</surname> <given-names>K.</given-names></name> <name><surname>Yang</surname> <given-names>F.</given-names></name> <name><surname>Chen</surname> <given-names>D.</given-names></name> <name><surname>Cai</surname> <given-names>S.</given-names></name> <name><surname>Huang</surname> <given-names>L.</given-names></name></person-group> (<year>2021</year>). <article-title>Association between structural brain features and gene expression by weighted gene co-expression network analysis in conversion from MCI to AD.</article-title> <source><italic>Behav. Brain Res.</italic></source> <volume>2021</volume>:<issue>113330</issue>.</citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>He</surname> <given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>BrainNet Viewer: a network visualization tool for human brain connectomics.</article-title> <source><italic>PloS One</italic></source> <volume>8</volume>:<issue>e68910</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0068910</pub-id> <pub-id pub-id-type="pmid">23861951</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>Z.</given-names></name> <name><surname>Rein</surname> <given-names>B.</given-names></name></person-group> (<year>2021</year>). <article-title>Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications.</article-title> <source><italic>Mol. Psychiatry</italic></source> <volume>2021</volume> <fpage>1</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-021-01092-3</pub-id> <pub-id pub-id-type="pmid">33875802</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>B.</given-names></name> <name><surname>Horvath</surname> <given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>A general framework for weighted gene co-expression network analysis.</article-title> <source><italic>Stat. Appl. Genet. Mol. Biol.</italic></source> <volume>4</volume>:<issue>1128</issue>. <pub-id pub-id-type="doi">10.2202/1544-6115.1128</pub-id> <pub-id pub-id-type="pmid">16646834</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y.</given-names></name> <name><surname>Zhou</surname> <given-names>B.</given-names></name> <name><surname>Pache</surname> <given-names>L.</given-names></name> <name><surname>Chang</surname> <given-names>M.</given-names></name> <name><surname>Khodabakhshi</surname> <given-names>A. H.</given-names></name> <name><surname>Tanaseichuk</surname> <given-names>O.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>10</volume> <fpage>1</fpage>&#x2013;<lpage>10</lpage>.</citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zilles</surname> <given-names>K.</given-names></name> <name><surname>Amunts</surname> <given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Segregation and wiring in the brain.</article-title> <source><italic>Science</italic></source> <volume>335</volume>:<issue>1582</issue>. <pub-id pub-id-type="doi">10.1126/science.1221366</pub-id> <pub-id pub-id-type="pmid">22461598</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p><ext-link ext-link-type="uri" xlink:href="http://adni.loni.usc.edu">adni.loni.usc.edu</ext-link></p></fn>
<fn id="footnote2">
<label>2</label>
<p><ext-link ext-link-type="uri" xlink:href="http://human.brain-map.org">http://human.brain-map.org</ext-link></p></fn>
<fn id="footnote3">
<label>3</label>
<p><ext-link ext-link-type="uri" xlink:href="https://github.com/SupingCai/PLSR-and-WGCNA-Codes">https://github.com/SupingCai/PLSR-and-WGCNA-Codes</ext-link></p></fn>
<fn id="footnote4">
<label>4</label>
<p><ext-link ext-link-type="uri" xlink:href="http://metascape.org/">http://metascape.org/</ext-link></p></fn>
<fn id="footnote5">
<label>5</label>
<p><ext-link ext-link-type="uri" xlink:href="http://amp.pharm.mssm.edu/Enrichr">http://amp.pharm.mssm.edu/Enrichr</ext-link></p></fn>
<fn id="footnote6">
<label>6</label>
<p><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/QuickGO">http://www.ebi.ac.uk/QuickGO</ext-link></p></fn>
</fn-group>
</back>
</article>